<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/rxrx" ></link>
<id>urn:uuid:8eaf2b0f-57de-13d1-9ceb-8522bed74b2a</id>
<updated>2026-08-24T23:31:44-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>RXRX: KHAN NAJAT (CEO,PR,DIR) Disposed (JS) 80,498 Shares of RECURSION PHARMACEUTICALS INC for $3.16 on 8/17</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6456292" ></link>
<id>urn:uuid:3c30fb04-659b-6171-096e-a90acd8818c8</id>
<updated>2026-08-18T17:44:34-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: HALLETT DAVID (O) Disposed (JS) 26,657 Shares of RECURSION PHARMACEUTICALS INC for $3.16 on 8/17</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6456293" ></link>
<id>urn:uuid:6c97f4ce-e68a-f02a-7f1e-6feb8adbfd28</id>
<updated>2026-08-18T17:44:29-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: TAYLOR BEN R (CFO) Disposed (JS) 25,018 Shares of RECURSION PHARMACEUTICALS INC for $3.16 on 8/17</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6456294" ></link>
<id>urn:uuid:2c70851d-51d2-24c7-d690-2f28416e8296</id>
<updated>2026-08-18T17:44:23-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: BORGESON BLAKE (DIR) Sold (AS) 30k Shares of RECURSION PHARMACEUTICALS INC for $3.25 on 8/4</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6450179" ></link>
<id>urn:uuid:539a9fdb-a637-6102-15d8-b6f06397f213</id>
<updated>2026-08-06T17:09:25-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: BORGESON BLAKE (DIR) Sold (AS) 40k Shares of RECURSION PHARMACEUTICALS INC for $3.96 on 7/7</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6440272" ></link>
<id>urn:uuid:b5e1aeed-7f38-69e9-e2a9-e9f62fb1d345</id>
<updated>2026-07-09T18:04:18-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: DAR ZAVAIN (DIR) Acquired (JB) 5,109 Shares of RECURSION PHARMACEUTICALS INC for $0.00 on 7/1</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6437010" ></link>
<id>urn:uuid:0d3b4412-307e-8a86-296f-1f98beb80d26</id>
<updated>2026-07-02T17:15:51-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: LI DEAN Y (DIR) Acquired (JB) 3,747 Shares of RECURSION PHARMACEUTICALS INC for $0.00 on 7/1</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6437000" ></link>
<id>urn:uuid:130a34ab-dcff-e78d-3568-f307251cdb97</id>
<updated>2026-07-02T17:15:43-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: BORGESON BLAKE (DIR) Acquired (JB) 88,424 Shares of RECURSION PHARMACEUTICALS INC for $0.00 on 6/17</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6430530" ></link>
<id>urn:uuid:a5b3ad74-c5e2-0d54-a50d-8df699f0b53f</id>
<updated>2026-06-22T16:32:41-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: HERSHBERG ROBERT (DIR) Acquired (JB) 88,424 Shares of RECURSION PHARMACEUTICALS INC for $0.00 on 6/17</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6430532" ></link>
<id>urn:uuid:fcd2bf9d-7fcc-2817-cd47-c3e49d7304f5</id>
<updated>2026-06-22T16:32:34-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
<entry>
<title>RXRX: MICHOR FRANZISKA (DIR) Acquired (JB) 88,424 Shares of RECURSION PHARMACEUTICALS INC for $0.00 on 6/17</title>
<link href="http://www.insiderinsights.com/company/rxrx/recursion-pharmaceuticals-inc/id-6430510" ></link>
<id>urn:uuid:8639c71f-a082-eff1-30b6-ac9e030d042f</id>
<updated>2026-06-22T16:32:28-04:00</updated>
<summary type="html" ><![CDATA[RECURSION PHARMACEUTICALS INC (RXRX). Recent Price: $3.50. Mkt Cap:1.9B. 10D Vol: 15.8mm]]></summary>
</entry>
</feed>